Filing Details
- Accession Number:
- 0001214659-22-001811
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-03 16:35:23
- Reporting Period:
- 2022-02-01
- Accepted Time:
- 2022-02-03 16:35:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581280 | Twist Bioscience Corp | TWST | Biological Products, (No Disgnostic Substances) (2836) | 462058888 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755970 | John Patrick Finn | C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-01 | 280 | $23.33 | 43,732 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-02-01 | 379 | $26.66 | 44,111 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-01 | 659 | $60.52 | 43,452 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2022-02-01 | 379 | $0.00 | 379 | $26.66 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2022-02-01 | 280 | $0.00 | 280 | $23.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 34,512 | 2028-11-18 | No | 4 | M | Direct | |
| 19,705 | 2029-10-23 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 16, 2021.
- 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Billionaire Hedge Funds
